September 7, 2026

Axsome Therapeutics (AXSM) Investor Outlook: Unveiling a 38% Upside Potential Amidst Rapid Growth in CNS Therapies

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a pioneering biopharmaceutical company, continues to capture the attention of investors with its robust growth trajectory in the healthcare sector, specifically in the biotechnology industry...

Legend Biotech Corporation (LEGN): Investor Outlook on a Biotech Powerhouse with a 128.84% Upside Potential

Legend Biotech Corporation (NASDAQ: LEGN) is making waves in the biotechnology sector, with a compelling narrative that positions it as a formidable player in the cell therapy landscape. Headquartered in..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Unveiling a 7.47% Potential Upside with Promising Genetic Medicine Innovations

Krystal Biotech, Inc. (NASDAQ: KRYS) has emerged as a formidable player in the biotechnology sector, focusing on the development and commercialization of genetic medicines aimed at addressing diseases with substantial..

RadNet, Inc. (RDNT) Stock Analysis: Exploring a Potential 28.37% Upside with Strong Buy Ratings

For investors seeking opportunities in the healthcare sector, RadNet, Inc. (NASDAQ: RDNT) presents an intriguing proposition. With a market capitalization of $5.8 billion, RadNet is a prominent player in the..

Nuvalent, Inc. (NUVL) Stock Analysis: What Investors Need to Know About This $9.81 Billion Biotech Player

Nuvalent, Inc. (NASDAQ: NUVL) is carving out its niche in the competitive biotechnology sector with a strong focus on developing innovative cancer therapies. With a market capitalization of $9.81 billion,..

Stevanato Group S.p.A. (STVN) Stock Analysis: Unlocking 21% Potential Upside for Healthcare Investors

Stevanato Group S.p.A. (NYSE: STVN), an Italian powerhouse in the healthcare sector, presents a compelling opportunity for investors with its diverse array of offerings in the medical instruments and supplies..

Genmab A/S (GMAB) Stock Analysis: Unveiling a 15.58% Potential Upside in Biotechnology

For investors seeking promising opportunities in the biotechnology sector, Genmab A/S (NASDAQ: GMAB) stands out with its robust portfolio and promising growth trajectory. Based out of Copenhagen, Denmark, this biotechnology..

TransMedics Group, Inc. (TMDX) Stock Analysis: Strong Buy Ratings and 8.14% Upside Potential

TransMedics Group, Inc. (NASDAQ: TMDX) stands out in the healthcare sector, specifically within the medical devices industry, for its innovative contributions to organ transplant therapy. With a market capitalization of..

Alcon Inc. (ALC) Stock Analysis: Exploring a Promising 20.91% Upside Potential

Alcon Inc. (NYSE: ALC), a global leader in eye care, is catching the attention of investors with a notable 20.91% potential upside. Operating in the healthcare sector, specifically within the..

Vaxcyte, Inc. (PCVX) Stock Analysis: Examining a Potential 78% Upside in the Biotech Frontier

Vaxcyte, Inc. (NASDAQ: PCVX), a pioneering player in the biotechnology sector, stands at the forefront of vaccine innovation, with a market capitalization of $9.1 billion. Specializing in conjugate and novel..

HealthEquity, Inc. (HQY) Investor Outlook: Analyst Ratings Signal a Promising 23.87% Potential Upside

HealthEquity, Inc. (HQY), a prominent player in the healthcare information services sector, is capturing the attention of investors with its robust growth metrics and impressive analyst ratings. With a market..

Corcept Therapeutics (CORT): Exploring the 26% Upside Potential in the Biotech Sector

Corcept Therapeutics Incorporated (CORT) is drawing significant attention in the biotech investment landscape with its compelling growth potential and strategic positioning. As a biopharmaceutical company operating within the healthcare sector,..

BioNTech SE (BNTX) Stock Analysis: Navigating Growth Amidst a 15.99% Upside Potential

BioNTech SE (NASDAQ: BNTX), a stalwart in the biotechnology sector, has been at the forefront of developing innovative immunotherapies. Known primarily for its mRNA-based COVID-19 vaccine, the company has a..

Agilent Technologies, Inc. (A) Investor Outlook: Analyzing a 16.30% Potential Upside in the Diagnostics Sector

Agilent Technologies, Inc. (NYSE: A) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $42.54 billion, this Santa..

AstraZeneca PLC (AZN) Stock Analysis: Unpacking a 30% Potential Upside with Strong Buy Ratings

AstraZeneca PLC (AZN), a leading giant in the healthcare sector, has been catching the eye of investors with its promising potential upside of 30.63%. As a major player in the..

AptarGroup, Inc. (ATR) Stock Analysis: A 33.54% Potential Upside Beckons Investors

AptarGroup, Inc. (NYSE: ATR), a key player in the healthcare sector, is garnering significant attention from investors looking to capitalize on its promising growth potential. With a market cap of..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: Strong Buy Ratings and a 17.28% Upside Potential

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a leading player in the biotechnology sector, is making waves in the healthcare industry with its robust portfolio of pharmaceutical products targeting a range of..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Navigating Growth Potential with a 17.97% Return on Equity

Inspire Medical Systems, Inc. (NASDAQ: INSP), a notable player in the healthcare sector, specializes in pioneering medical devices designed to tackle obstructive sleep apnea (OSA). With a market capitalization of..

Guardant Health, Inc. (GH) Stock Analysis: Unveiling a 20% Potential Upside with Strong Buy Ratings

Guardant Health, Inc. (NASDAQ: GH), a leader in precision oncology, is making waves in the healthcare sector with its innovative diagnostics and research solutions. Based in Palo Alto, California, the..

iRhythm Holdings, Inc. (IRTC): Analyst Ratings Signal a Promising 43% Upside for Investors

iRhythm Holdings, Inc. (NASDAQ: IRTC) is capturing investor attention with its robust growth potential in the healthcare sector, specifically within the medical devices industry. The San Francisco-based company specializes in..

Search

Funds

September 7, 2026

Search

Funds

September 7, 2026

FTSE 100

Funds